Inotersen Improves Quality of Life and Neuropathy in Patients with Hereditary Transthyretin (HATTR) Amyloidosis with Polyneuropathy- Results of the Phase 3 Study Neuro-TTR

May 1, 2018, 00:00
10.1016/j.jval.2018.04.1376
https://www.valueinhealthjournal.com/article/S1098-3015(18)31682-6/fulltext
Title : Inotersen Improves Quality of Life and Neuropathy in Patients with Hereditary Transthyretin (HATTR) Amyloidosis with Polyneuropathy- Results of the Phase 3 Study Neuro-TTR
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31682-6&doi=10.1016/j.jval.2018.04.1376
First page :
Section Title :
Open access? : No
Section Order : 626
Categories :
Tags :
Regions :
ViH Article Tags :